Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Large-Cell, Anaplastic

Explore clinical trials studying Lymphoma, Large-Cell, Anaplastic. Study availability and eligibility vary by location and protocol.

289 public trials 18 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Large-Cell, Anaplastic trial results

Completed

A Brentuximab Vedotin Trial for Patients Who Have Previously Participated in a Brentuximab Vedotin Study

NCT00947856

Conditions
Disease, Hodgkin, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
View all 17 locations
View Trial Details
Completed

Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer

NCT00053053

Conditions
Body Weight, Body Weight Changes, Burkitt Lymphoma, +44 more
Locations
  • Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
  • Comprehensive Cancer Institute Huntsville, Alabama, United States
  • MBCCOP - Gulf Coast Mobile, Alabama, United States
  • Montgomery Cancer Center Montgomery, Alabama, United States
View all 250 locations
View Trial Details
Completed

Combination Chemotherapy in Treating Patients With Relapsed or Refractory Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

NCT00006125

Conditions
Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +18 more
Locations
  • Northeast Alabama Regional Medical Center Anniston, Alabama, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Diego San Diego, California, United States
  • UCSF Comprehensive Cancer Center San Francisco, California, United States
View all 76 locations
View Trial Details
Completed

Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment

NCT00006348

Conditions
Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +100 more
Locations
  • CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
  • CCOP - Carle Cancer Center Urbana, Illinois, United States
  • CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States
  • Siouxland Hematology-Oncology Sioux City, Iowa, United States
View Trial Details
Completed

Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma

NCT01466881

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +23 more
Locations
  • Providence Hospital Mobile, Alabama, United States
  • The University of Arizona Cancer Center-Orange Grove Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • The University of Arizona Medical Center-University Campus Tucson, Arizona, United States
View all 161 locations
View Trial Details
Completed

MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or Lymphoma

NCT01748721

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +103 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital of Orange County Orange, California, United States
  • University of California San Francisco Medical Center - Parnassus San Francisco, California, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 20 locations
View Trial Details

Related conditions